EA201001139A1 - УЛУЧШЕННЫЕ АНТИТЕЛА АНТИ-TrkB - Google Patents
УЛУЧШЕННЫЕ АНТИТЕЛА АНТИ-TrkBInfo
- Publication number
- EA201001139A1 EA201001139A1 EA201001139A EA201001139A EA201001139A1 EA 201001139 A1 EA201001139 A1 EA 201001139A1 EA 201001139 A EA201001139 A EA 201001139A EA 201001139 A EA201001139 A EA 201001139A EA 201001139 A1 EA201001139 A1 EA 201001139A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- trkb
- antibody anti
- improved antibody
- polynucleotides
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В заявке описаны улучшенные антитела или антигенсвязывающие соединения, которые специфически связываются с рецепторной тирозинкиназой В (TrkB) или являются ее агонистами, а также способы их получения. В заявке описаны также полинуклеотиды и векторы, кодирующие такие соединения, и клетки-хозяина, включающие указанные полинуклеотиды или векторы.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2182008P | 2008-01-17 | 2008-01-17 | |
US61/021,820 | 2008-01-17 | ||
PCT/US2009/031345 WO2009092049A1 (en) | 2008-01-17 | 2009-01-16 | Improved anti-trkb antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201001139A1 true EA201001139A1 (ru) | 2011-04-29 |
EA028621B1 EA028621B1 (ru) | 2017-12-29 |
Family
ID=40627621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001139A EA028621B1 (ru) | 2008-01-17 | 2009-01-16 | АНТИТЕЛО ИЛИ ЕГО АНТИГЕНСВЯЗЫВАЮЩИЙ ФРАГМЕНТ, КОТОРЫЙ СПЕЦИФИЧНО СВЯЗЫВАЕТ РЕЦЕПТОРНУЮ ТИРОЗИНКИНАЗУ (TrkB), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЭТО АНТИТЕЛО ИЛИ ЕГО АНТИГЕНСВЯЗЫВАЮЩИЙ ФРАГМЕНТ, И КОМБИНАЦИЯ, ВКЛЮЧАЮЩАЯ УКАЗАННУЮ КОМПОЗИЦИЮ |
Country Status (15)
Country | Link |
---|---|
US (1) | US8642035B2 (ru) |
EP (1) | EP2235062A1 (ru) |
JP (1) | JP5420568B2 (ru) |
KR (1) | KR101290503B1 (ru) |
CN (1) | CN102015769B (ru) |
AR (1) | AR070202A1 (ru) |
AU (1) | AU2009205937B2 (ru) |
BR (1) | BRPI0906877A2 (ru) |
CA (1) | CA2712298C (ru) |
CL (1) | CL2009000090A1 (ru) |
EA (1) | EA028621B1 (ru) |
MX (1) | MX2010007841A (ru) |
PE (1) | PE20091326A1 (ru) |
TW (1) | TW200936608A (ru) |
WO (1) | WO2009092049A1 (ru) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010033941A1 (en) | 2008-09-22 | 2010-03-25 | Array Biopharma Inc. | Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors |
RU2523544C2 (ru) | 2008-10-22 | 2014-07-20 | Эррэй Биофарма Инк. | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ ТРК КИНАЗЫ |
AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
WO2011036297A2 (de) * | 2009-09-27 | 2011-03-31 | Ruhr-Universität-Bochum | Verfahren zur therapie und diagnose von morbus alzheimer |
SI3205654T1 (sl) | 2010-05-20 | 2019-07-31 | Array Biopharma, Inc. | Makrociklične spojine kot inhibitorji TRK kinaze |
US9880160B2 (en) | 2011-03-15 | 2018-01-30 | X-Body, Inc. | Antibody screening methods |
CN102830228B (zh) * | 2011-06-15 | 2015-01-21 | 格诺思博生物科技(上海)有限公司 | 定量分析循环肿瘤细胞的试剂及试剂盒 |
CN102944674B (zh) * | 2012-11-05 | 2014-10-22 | 武汉远征世纪制药有限公司 | 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法 |
EP2948135B1 (en) * | 2013-01-25 | 2019-01-02 | Case Western Reserve University | Compositions and methods for the treatment of pervasive development disorders |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
BR112015032540A2 (pt) * | 2013-06-26 | 2017-07-25 | Baylor College Medicine | síndrome de rett e tratamentos para a mesma |
SI3699181T1 (sl) | 2014-11-16 | 2023-06-30 | Array Biopharma, Inc. | Kristalinična oblika(s)-n-(5-((r)-2-(2,5-difluorofenil)- pirolidin-1-il)-pirazolo(1,5-a)pirimidin-3-il)-3-hidroksipirolidin-1 -karboksamid hidrogen sulfata |
CN104524568B (zh) * | 2015-01-08 | 2018-04-20 | 中国人民解放军第二军医大学 | 一种治疗肥胖症的药物组合物及其应用 |
US9869297B2 (en) | 2015-05-07 | 2018-01-16 | General Electric Company | Attachment method and system to install components, such as vortex generators, to a wind turbine blade |
US9869296B2 (en) | 2015-05-07 | 2018-01-16 | General Electric Company | Attachment method and system to install components, such as tip extensions and winglets, to a wind turbine blade |
US9869295B2 (en) | 2015-05-07 | 2018-01-16 | General Electric Company | Attachment method to install components, such as tip extensions and winglets, to a wind turbine blade, as well as the wind turbine blade and component |
KR20180021745A (ko) | 2015-06-01 | 2018-03-05 | 록쏘 온콜로지, 인코포레이티드 | 암을 진단하고 치료하는 방법 |
ES2857081T3 (es) | 2015-07-16 | 2021-09-28 | Array Biopharma Inc | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret |
US10100805B2 (en) | 2015-10-12 | 2018-10-16 | General Electric Compant | Tip extension assembly for a wind turbine rotor blade |
WO2017075107A1 (en) | 2015-10-26 | 2017-05-04 | Nanda Nisha | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
AU2016356877A1 (en) | 2015-11-17 | 2018-05-10 | Glaxosmithkline Intellectual Property Development Limited | Binding agonists for treatment of neurological and other disorders |
CA3019661A1 (en) | 2016-04-04 | 2017-10-12 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
EP3439662A1 (en) | 2016-04-04 | 2019-02-13 | Loxo Oncology Inc. | Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
US11214571B2 (en) | 2016-05-18 | 2022-01-04 | Array Biopharma Inc. | Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof |
JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
WO2018069927A1 (en) * | 2016-10-10 | 2018-04-19 | The National Institute for Biotechnology in the Negev Ltd. | Non-cytotoxic modified cells and use thereof |
US11286295B2 (en) * | 2016-10-20 | 2022-03-29 | Sanofi | Anti-CHIKV monoclonal antibodies directed against the E2 structural protein |
JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
US9914781B1 (en) | 2016-11-08 | 2018-03-13 | Glaxosmithkline Intellectual Property Development Limited | Binding agonist for treatment of neurological and other disorders |
US10443579B2 (en) | 2016-11-15 | 2019-10-15 | General Electric Company | Tip extensions for wind turbine rotor blades and methods of installing same |
US11168090B2 (en) | 2017-01-18 | 2021-11-09 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors |
WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
US10830206B2 (en) | 2017-02-03 | 2020-11-10 | General Electric Company | Methods for manufacturing wind turbine rotor blades and components thereof |
US11098691B2 (en) | 2017-02-03 | 2021-08-24 | General Electric Company | Methods for manufacturing wind turbine rotor blades and components thereof |
JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
WO2018226785A1 (en) * | 2017-06-06 | 2018-12-13 | University Of Massachusetts | Self-regulating aav vectors for safe expression of mecp2 in rett syndrome |
US10793634B2 (en) * | 2017-06-09 | 2020-10-06 | Boehringer Ingelheim International Gmbh | Anti-TrkB antibodies |
TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
MA50456A (fr) | 2017-10-26 | 2020-09-02 | Array Biopharma Inc | Formulations d'un inhibiteur de kinase trk macrocyclique |
US11390013B2 (en) | 2017-11-21 | 2022-07-19 | General Electric Company | Vacuum forming mold assembly and associated methods |
US10913216B2 (en) | 2017-11-21 | 2021-02-09 | General Electric Company | Methods for manufacturing wind turbine rotor blade panels having printed grid structures |
US11248582B2 (en) | 2017-11-21 | 2022-02-15 | General Electric Company | Multiple material combinations for printed reinforcement structures of rotor blades |
US11040503B2 (en) | 2017-11-21 | 2021-06-22 | General Electric Company | Apparatus for manufacturing composite airfoils |
US10865769B2 (en) | 2017-11-21 | 2020-12-15 | General Electric Company | Methods for manufacturing wind turbine rotor blade panels having printed grid structures |
US10821652B2 (en) | 2017-11-21 | 2020-11-03 | General Electric Company | Vacuum forming mold assembly and method for creating a vacuum forming mold assembly |
US10773464B2 (en) | 2017-11-21 | 2020-09-15 | General Electric Company | Method for manufacturing composite airfoils |
US10920745B2 (en) | 2017-11-21 | 2021-02-16 | General Electric Company | Wind turbine rotor blade components and methods of manufacturing the same |
US11668275B2 (en) | 2017-11-21 | 2023-06-06 | General Electric Company | Methods for manufacturing an outer skin of a rotor blade |
BR112020006976A2 (pt) * | 2017-11-30 | 2020-10-13 | Regeneron Pharmaceuticals, Inc. | anticorpos monoclonais anti-trkb e métodos de uso |
WO2019143994A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
CA3087578C (en) | 2018-01-18 | 2023-08-08 | Array Biopharma Inc. | Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors |
US11603374B2 (en) | 2018-01-18 | 2023-03-14 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
CN108265036B (zh) * | 2018-01-26 | 2021-04-27 | 山东大学齐鲁医院 | 一种沉默t1蛋白的重组病毒及其构建方法与应用 |
US11035339B2 (en) | 2018-03-26 | 2021-06-15 | General Electric Company | Shear web assembly interconnected with additive manufactured components |
US10821696B2 (en) | 2018-03-26 | 2020-11-03 | General Electric Company | Methods for manufacturing flatback airfoils for wind turbine rotor blades |
CA3095366A1 (en) | 2018-03-29 | 2019-10-03 | Loxo Oncology, Inc. | Treatment of trk-associated cancers |
KR102612513B1 (ko) | 2018-07-31 | 2023-12-12 | 록쏘 온콜로지, 인코포레이티드 | (s)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1h-피라졸-4-카르복스아미드의 분무-건조된 분산물 및 제제 |
CN112996794A (zh) | 2018-09-10 | 2021-06-18 | 阿雷生物药品公司 | 作为ret激酶抑制剂的稠合杂环化合物 |
US20220081438A1 (en) | 2018-12-19 | 2022-03-17 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases |
CN113474337A (zh) | 2018-12-19 | 2021-10-01 | 奥瑞生物药品公司 | 作为fgfr抑制剂用于治疗癌症的7-((3,5-二甲氧基苯基)氨基)喹喔啉衍生物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU22979A1 (es) | 2000-12-08 | 2004-09-09 | Centro Inmunologia Molecular | Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina |
EP1517921B1 (en) * | 2002-06-28 | 2006-06-07 | Domantis Limited | Dual specific ligands with increased serum half-life |
AU2007316418A1 (en) * | 2006-11-09 | 2008-05-15 | Irm Llc | Agonist TrkB antibodies and uses thereof |
US20100297115A1 (en) * | 2007-10-23 | 2010-11-25 | Novartis Ag | Use of trkb antibodies for the treatment of respiratory disorders |
-
2009
- 2009-01-16 AU AU2009205937A patent/AU2009205937B2/en not_active Ceased
- 2009-01-16 CL CL2009000090A patent/CL2009000090A1/es unknown
- 2009-01-16 KR KR1020107018153A patent/KR101290503B1/ko active IP Right Grant
- 2009-01-16 EA EA201001139A patent/EA028621B1/ru not_active IP Right Cessation
- 2009-01-16 WO PCT/US2009/031345 patent/WO2009092049A1/en active Application Filing
- 2009-01-16 CN CN200980109719.6A patent/CN102015769B/zh not_active Expired - Fee Related
- 2009-01-16 US US12/864,636 patent/US8642035B2/en active Active
- 2009-01-16 MX MX2010007841A patent/MX2010007841A/es active IP Right Grant
- 2009-01-16 BR BRPI0906877-5A patent/BRPI0906877A2/pt not_active Application Discontinuation
- 2009-01-16 TW TW098101724A patent/TW200936608A/zh unknown
- 2009-01-16 JP JP2010543295A patent/JP5420568B2/ja not_active Expired - Fee Related
- 2009-01-16 PE PE2009000058A patent/PE20091326A1/es not_active Application Discontinuation
- 2009-01-16 CA CA2712298A patent/CA2712298C/en not_active Expired - Fee Related
- 2009-01-16 EP EP09702204A patent/EP2235062A1/en not_active Ceased
- 2009-01-19 AR ARP090100159A patent/AR070202A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR070202A1 (es) | 2010-03-17 |
EP2235062A1 (en) | 2010-10-06 |
JP2011510021A (ja) | 2011-03-31 |
PE20091326A1 (es) | 2009-09-18 |
TW200936608A (en) | 2009-09-01 |
AU2009205937B2 (en) | 2013-02-07 |
CN102015769B (zh) | 2014-12-10 |
CA2712298A1 (en) | 2009-07-23 |
US20110097326A1 (en) | 2011-04-28 |
CN102015769A (zh) | 2011-04-13 |
AU2009205937A1 (en) | 2009-07-23 |
MX2010007841A (es) | 2010-09-28 |
WO2009092049A1 (en) | 2009-07-23 |
US8642035B2 (en) | 2014-02-04 |
JP5420568B2 (ja) | 2014-02-19 |
KR20100103693A (ko) | 2010-09-27 |
BRPI0906877A2 (pt) | 2015-07-28 |
EA028621B1 (ru) | 2017-12-29 |
CL2009000090A1 (es) | 2009-07-24 |
KR101290503B1 (ko) | 2013-07-26 |
CA2712298C (en) | 2015-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001139A1 (ru) | УЛУЧШЕННЫЕ АНТИТЕЛА АНТИ-TrkB | |
EA201790757A1 (ru) | Связывающие антиген cd27l белки | |
JOP20190017A1 (ar) | أجسام مضادة ترتبط مع مستقبل cgrp بشري | |
CO6280541A2 (es) | Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40 | |
EA202192103A1 (ru) | Антитела и химерные антигенные рецепторы, специфичные к орфанному рецептору типа рецеторной тирозинкиназы 1 (ror1) | |
EA201891066A1 (ru) | Антитела к ror1 | |
EA201170030A1 (ru) | Il-6-опосредованная иммунотерапия | |
NO20081987L (no) | Humane, monoklonale antistoffer mot CD70 | |
EA201291181A1 (ru) | Композиции и способы применения терапевтических поливалентных антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6) | |
EA201100868A1 (ru) | Противоопухолевые комбинации, содержащие антитела, специфически распознающие cd38, и цитарабин | |
BR112014019579A8 (pt) | Anticorpos, polinucleotídeos, vetores, métodos de produção de um anticorpo, heteromultímero, método de produção de um heteromultímero e célula hospedeira | |
EA201591091A1 (ru) | Антигенсвязывающие белки для bcma | |
EA201001223A1 (ru) | Стабилизированные белковые композиции | |
EA201500316A1 (ru) | Антагонисты толл-подобного рецептора 3 | |
NO20073797L (no) | Humane monoklonale antistoffer mot prostata spesifikt membran antigen (PSMA) | |
NO20083053L (no) | Humane monoklonale antistoffer mot O8E | |
EA200702402A1 (ru) | Агенты, связывающие склеростин | |
EA201400568A1 (ru) | Альбуминсвязывающие антитела и их связывающие фрагменты | |
TR201901841T4 (tr) | Her antikorlarının sabit dozlaması. | |
EA200801621A1 (ru) | Антитела, направленные на her-3, и их применение | |
EA201190041A1 (ru) | Человеческие аутоантитела против альфа-синуклеина | |
EA201000471A1 (ru) | Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин | |
CL2009000459A1 (es) | Anticuerpo se une a la proteina rgm a; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; construccion de anticuerpos que comprende dicha proteina; conjugado de anticuerpos que comprende a la construccion; uso. | |
MX341309B (es) | Anticuerpos especificos del heterodimero de anti-il-23. | |
EA201101516A1 (ru) | Антитела, специфические для кадгерина-17 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |